Contribution of Cholesteryl Ester Transfer Protein and Lecithin:Cholesterol Acyltransferase to HDL Size Distribution

References

• Wilson P W, Garrison R J, Castelli W P, Feinleib M, McNamara P M, Kannel W B. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 1980; 46(4)649–654
   PubMed Web of Science ®Google Scholar
• Assmann G, Schulte H, von Eckardstein A, Huang Y. High‐density lipoprotein cholesterol as a predictor of coronary heart disease risk: the PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124: S11–S20
   PubMed Web of Science ®Google Scholar
• Schaefer E J, Lamon‐Fava S, Ordovas J M, Cohn S D, Schaefer M M, Castelli W P, Wilson P W. Factors associated with low and elevated plasma high‐density lipoprotein cholesterol and apolipoprotein A–I levels in the Framingham Offspring Study. J Lipid Res 1994; 35: 871–882
   PubMed Web of Science ®Google Scholar
• Wilson P WF, D'Agostino R B, Levy D, Belanger A M, Silbershatz H, Kannel W B. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847
   PubMed Web of Science ®Google Scholar
• Bloomfield–Rubins H, Davenport J, Babikian V, Brass L M, Collins D, Wexler L, Wagner S, Papademetriou V, Rutan G, Robins S J, VA‐HIT Study Group. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA‐HIT). Circulation 2001; 103: 2828–2833
   PubMed Web of Science ®Google Scholar
• Sviridov D, Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002; 161: 245–254
   PubMed Web of Science ®Google Scholar
• Nofer J R, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002; 161: 1–16
   PubMed Web of Science ®Google Scholar
• Castro G R, Fielding C J. Early incorporation of cell‐derived cholesterol into pre‐β‐migrating high density lipoprotein pathway. Biochemistry 1988; 27: 25–29
   PubMed Web of Science ®Google Scholar
• Deakin S, Leviev I, Gomaraschi M, Calabresi L, Franceschini G, James R W. Enzymatically active paraoxonase‐1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 2002; 277: 4301–4308
   PubMed Web of Science ®Google Scholar
• Kontush A, Chantepie S, Chapman M J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23: 1881–1888
   PubMed Web of Science ®Google Scholar
• Huesca‐Gómez C, Franco M, Luc G, Montano L F, Masso F, Posadas‐Romero C, Perez‐Mendez O. Chronic hypothyroidism induces abnormal structure of high‐density lipoproteins and impaired kinetics of apolipoprotein A–I in the rat. Metabolism 2002; 51: 443–450
   PubMed Web of Science ®Google Scholar
• Tato F, Vega G L, Grundy S M. Determinants of plasma HDL‐cholesterol in hypertriglyceridemic patients. Role of cholesterol‐ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol 1997; 17: 56–63
   PubMed Web of Science ®Google Scholar
• Kuivenhoven J A, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 1997; 38: 191–205
   PubMed Web of Science ®Google Scholar
• Elkhalil L, Majd Z, Bakir R, Perez‐Mendez O, Castro G, Poulain P, Lacroix B, Duhal N, Fruchart J C, Luc G. Fish‐eye disease: structural and in vivo metabolic abnormalities of high‐density lipoproteins. Metabolism 1997; 46: 474–483
   PubMed Web of Science ®Google Scholar
• Hoeg J M, Vaisman B L, Demosky S J, Jr, Meyn S M, Talley G D, Hoyt R F, Jr, Feldman S, Berard A M, Sakai N, Wood D, Brousseau M E, Marcovina S, Brewer H B, Jr, Santamarina‐Fojo S. Lecithin: cholesterol acyltransferase overexpression generates hyperalpha‐lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J Biol Chem 1996; 271: 4396–4402
   PubMed Web of Science ®Google Scholar
• Hoeg J M, Santamarina‐Fojo S, Berard A M, Cornhill J F, Herderick E E, Feldman S H, Haudenschild C C, Vaisman B L, Hoyt R F, Jr, Demosky S J, Jr, Kauffman R D, Hazel C M, Marcovina S M, Brewer H B, Jr. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet‐induced atherosclerosis. Proc Natl Acad Sci U S A 1996; 93: 11448–11453
   PubMed Web of Science ®Google Scholar
• Francone O L, Haghpassand M, Bennett J A, Royer L, McNeish J. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. J Lipid Res 1997; 38: 813–822
   PubMed Web of Science ®Google Scholar
• Berard A M, Foger B, Remaley A, Shamburek R, Vaisman B L, Talley G, Paigen B, Hoyt R F, Jr, Marcovina S, Brewer H B, Jr, Santamarina‐Fojo S. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin‐cholesteryl acyltransferase. Nat Med 1997; 3: 744–749
   PubMed Web of Science ®Google Scholar
• Foger B, Chase M, Amar M J, Vaisman B L, Shamburek R D, Paigen B, Fruchart‐Najib J, Paiz J A, Koch C A, Hoyt R F, Brewer H B, Jr, Santamarina‐Fojo S. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem 1999; 274: 36912–36920
   PubMed Web of Science ®Google Scholar
• Yamashita S, Maruyama T, Hirano K, Sakai N, Nakajima N, Matsuzawa Y. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis 2000; 152: 271–285
   PubMed Web of Science ®Google Scholar
• Barter P J, Brewer H B, Chapman M J, Hennekens C H, Rader D J, Tall A R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 160–167
   PubMed Web of Science ®Google Scholar
• Chen C, Albers J J. Characterization of proteoliposomes containing apoprotein A–I. A new substrate for the measurement of lecithin cholesterol acyltransferase activity. J Lipid Res 1982; 23: 680–691
   PubMed Web of Science ®Google Scholar
• Tollefson H J, Albers J J. Isolation, characterization, and assay of plasma lipid transfer proteins. Methods of Enzymology, J J Albers, J P Segrest. Academic, New York 1986; Vol. 129: 797–816
   Google Scholar
• Williams P T, Krauss R M, Nichols A V, Vranizan K M, Wood P D. Identifying the predominant peak diameter of high‐density and low‐density lipoproteins by electrophoresis. J Lipid Res 1990; 31: 1131–1139
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421
   PubMed Web of Science ®Google Scholar
• Ordovas J M, Cupples L A, Corella D, Otvos J D, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson P W, Schaefer E J. Association of cholesteryl ester transfer protein‐TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000; 20: 1323–1329
   PubMed Web of Science ®Google Scholar
• Miida T, Miyazaki O, Hanyu O, Nakamura Y, Hirayama S, Narita I, Gejyo F, Ei I, Tasaki K, Kohda Y, Ohta T, Yata S, Fukamachi I, Okada M. LCAT‐dependent conversion of prebeta1‐HDL into alpha‐migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol 2003; 14: 732–738
   PubMed Web of Science ®Google Scholar
• Pascot A, Lemieux I, Bergeron J, Tremblay A, Nadeau A, Prud'homme D, Couillard C, Lamarche B, Despres J P. HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis 2002; 160: 399–406
   PubMed Web of Science ®Google Scholar
• Lamarche B, Moorjani S, Cantin B, Dagenais G R, Lupien P J, Despres J P. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 1997; 17: 1098–1105
   PubMed Web of Science ®Google Scholar
• Dobiasova M, Stribrna J, Pritchard P H, Frohlich J J. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle‐aged and septuagenarian men. J Lipid Res 1992; 33: 1411–1418
   PubMed Web of Science ®Google Scholar
• Webb N R, Cai L, Ziemba K S, Yu J, Kindy M S, van der Westhuyzen D R, de Beer F C. The fate of HDL particles in vivo after SR‐BI‐mediated selective lipid uptake. J Lipid Res 2002; 43: 1890–1898
   PubMed Web of Science ®Google Scholar
• Mardones P, Pilon A, Bouly M, Duran D, Nishimoto T, Arai H, Kozarsky K F, Altayo M, Miquel J F, Luc G, Clavey V, Staels B, Rigotti A. Fibrates down‐regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem 2003; 278: 7884–7890
   PubMed Web of Science ®Google Scholar
• de Beer M C, Durbin D M, Cai L, Jonas A, de Beer F C, van der Westhuyzen D R. Apolipoprotein A–I conformation markedly influences HDL interaction with scavenger receptor BI. J Lipid Res 2001; 42: 309–313
   PubMed Web of Science ®Google Scholar
• Rye K A, Jauhiainen M, Barter P J, Ehnholm C. Triglyceride‐enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res 1998; 39: 613–622
   PubMed Web of Science ®Google Scholar
• Botham K M, Avella M, Cantafora A, Bravo E. The hepatic uptake of rat high‐density lipoprotein cholesteryl ester is delayed after treatment with cholesteryl ester transfer protein. Proc Soc Exp Biol Med 1999; 220: 31–38
   PubMed Web of Science ®Google Scholar
• Brousseau M E, Santamarina‐Fojo S, Vaisman B L, Applebaum‐Bowden D, Berard A M, Talley G D, Brewer H B, Jr, Hoeg J M. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol‐fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose‐dependent manner. J Lipid Res 1997; 38: 2537–2547
   PubMed Web of Science ®Google Scholar
• Guerin M, Le Goff W, Frisdal E, Schneider S, Milosavljevic D, Bruckert E, Chapman M J. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high‐density lipoprotein‐mediated cellular cholesterol efflux. J Clin Endocrinol Metab 2003; 88: 3738–3746
   PubMed Web of Science ®Google Scholar